Home > Financial Ratios > KWALITY PHARMACEUTICALS

KWALITY PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for KWALITY PHARMACEUTICALS
Please provide your vote to see the results

KWALITY PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 7.596.313.673.073.36

What is the latest EV/Core EBITDA ratio of KWALITY PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of KWALITY PHARMACEUTICALS is 7.59 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar20247.59
Mar20236.31
Mar20223.67
Mar20213.07
Mar20203.36

How is EV/Core EBITDA of KWALITY PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2024 7.59
20.29
Mar2023 6.31
71.93
Mar2022 3.67
19.54
Mar2021 3.07
-8.63
Mar2020 3.36 -

Other Financial Ratios of KWALITY PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of KWALITY PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
KWALITY PHARMACEUTICALS ₹729.1 Cr -1% -19.1% 35.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹394,223.0 Cr -4.1% -9.8% 8.2% Stock Analytics
DIVIS LABORATORIES ₹152,610.0 Cr -2.9% -0.3% 63.8% Stock Analytics
CIPLA ₹119,067.0 Cr 0.1% 4.4% 2.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹102,744.0 Cr -1.3% -6.5% 19% Stock Analytics
DR REDDYS LABORATORIES ₹96,123.8 Cr -4% -5.9% -7.8% Stock Analytics


KWALITY PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
KWALITY PHARMACEUTICALS

-1%

-19.1%

35.9%

SENSEX

-0.8%

-1.6%

3.1%


You may also like the below Video Courses